InvestingSagimet Biosciences stock surges 30% on acne trial plans sai4 hours ago01 mins Sagimet Biosciences stock surges 30% on acne trial plans Source link Post navigation Previous: Labour figures criticise calls for inquiry into PM's Mandelson claimsNext: Is this Samsung’s upcoming wide foldable? Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Bill Ackman’s Pershing Square IPO expected to raise $5 billion, Bloomberg News reports sai18 minutes ago 0
AI casts existential shadow over legacy software companies, Bridgewater CIOs warn sai32 minutes ago 0